187 related articles for article (PubMed ID: 34928512)
1. The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers.
Lima VA; Esquinelato R; Carmo-Gonçalves P; Nascimento LAD; Lee H; Eliezer D; Romão L; Follmer C
FEBS Lett; 2022 Feb; 596(3):309-322. PubMed ID: 34928512
[TBL] [Abstract][Full Text] [Related]
2.
Carmo-Gonçalves P; Romão L; Follmer C
ACS Chem Neurosci; 2020 Nov; 11(21):3541-3548. PubMed ID: 33080132
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Svarcbahs R; Julku UH; Myöhänen TT
J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
[TBL] [Abstract][Full Text] [Related]
4. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein.
Carmo-Gonçalves P; do Nascimento LA; Cortines JR; Eliezer D; Romão L; Follmer C
Biochem Biophys Res Commun; 2018 Oct; 505(1):295-301. PubMed ID: 30249394
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection.
Carmo-Gonçalves P; Coelho-Cerqueira E; de Araujo Lima V; Follmer C
Expert Rev Neurother; 2023 Apr; 23(4):321-330. PubMed ID: 37016954
[TBL] [Abstract][Full Text] [Related]
6. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
[TBL] [Abstract][Full Text] [Related]
7. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.
Lima VA; do Nascimento LA; Eliezer D; Follmer C
ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158
[TBL] [Abstract][Full Text] [Related]
8. Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein.
Landeck N; Strathearn KE; Ysselstein D; Buck K; Dutta S; Banerjee S; Lv Z; Hulleman JD; Hindupur J; Lin LK; Padalkar S; Stanciu LA; Lyubchenko YL; Kirik D; Rochet JC
Mol Neurodegener; 2020 Sep; 15(1):49. PubMed ID: 32900375
[TBL] [Abstract][Full Text] [Related]
9. Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain.
Coelho-Cerqueira E; de Araújo Correia Campos C; Follmer C
Biochem Biophys Res Commun; 2019 Feb; 509(2):367-372. PubMed ID: 30591215
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers.
Dokleja L; Hannula MJ; Myöhänen TT
Neurosci Lett; 2014 Nov; 583():37-42. PubMed ID: 25240592
[TBL] [Abstract][Full Text] [Related]
11. Toxic effects of human and rodent variants of alpha-synuclein in vivo.
Landeck N; Buck K; Kirik D
Eur J Neurosci; 2017 Feb; 45(4):536-547. PubMed ID: 27893183
[TBL] [Abstract][Full Text] [Related]
12. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
[TBL] [Abstract][Full Text] [Related]
13. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
[TBL] [Abstract][Full Text] [Related]
14. The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis.
Sant'Anna R; Robbs BK; de Freitas JA; Dos Santos PP; König A; Outeiro TF; Foguel D
Mol Med; 2023 Aug; 29(1):111. PubMed ID: 37596531
[TBL] [Abstract][Full Text] [Related]
15. Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation.
Pieger K; Schmitt V; Gauer C; Gießl N; Prots I; Winner B; Winkler J; Brandstätter JH; Xiang W
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009004
[TBL] [Abstract][Full Text] [Related]
16. Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.
Bennett NK; Chmielowski R; Abdelhamid DS; Faig JJ; Francis N; Baum J; Pang ZP; Uhrich KE; Moghe PV
Biomaterials; 2016 Dec; 111():179-189. PubMed ID: 27736702
[TBL] [Abstract][Full Text] [Related]
17. Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.
Ysselstein D; Joshi M; Mishra V; Griggs AM; Asiago JM; McCabe GP; Stanciu LA; Post CB; Rochet JC
Neurobiol Dis; 2015 Jul; 79():150-63. PubMed ID: 25931201
[TBL] [Abstract][Full Text] [Related]
18. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.
Wang W; Nguyen LT; Burlak C; Chegini F; Guo F; Chataway T; Ju S; Fisher OS; Miller DW; Datta D; Wu F; Wu CX; Landeru A; Wells JA; Cookson MR; Boxer MB; Thomas CJ; Gai WP; Ringe D; Petsko GA; Hoang QQ
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9587-92. PubMed ID: 27482083
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity.
Ferreira DG; Batalha VL; Vicente Miranda H; Coelho JE; Gomes R; Gonçalves FQ; Real JI; Rino J; Albino-Teixeira A; Cunha RA; Outeiro TF; Lopes LV
Cereb Cortex; 2017 Jan; 27(1):718-730. PubMed ID: 26534909
[TBL] [Abstract][Full Text] [Related]
20. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease.
Kumar R; Chowdhury S; Ledeen R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
